INTEGRATED BIOPHARMA INC Annual Interest Expense in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Integrated Biopharma Inc quarterly/annual Interest Expense history and growth rate from 2011 to 2024.
  • Integrated Biopharma Inc Interest Expense for the quarter ending June 30, 2024 was $58K, a 61.1% increase year-over-year.
  • Integrated Biopharma Inc Interest Expense for the twelve months ending June 30, 2024 was $52K, unchanged year-over-year.
  • Integrated Biopharma Inc annual Interest Expense for 2024 was $52K, unchanged from 2023.
  • Integrated Biopharma Inc annual Interest Expense for 2023 was $52K, a 59.4% decline from 2022.
  • Integrated Biopharma Inc annual Interest Expense for 2022 was $128K, a 50% decline from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $52K $0 0% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-20
2023 $52K -$76K -59.4% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-20
2022 $128K -$128K -50% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-15
2021 $256K -$141K -35.5% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-13
2020 $397K -$233K -37% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-02
2019 $630K -$296K -32% Jul 1, 2018 Jun 30, 2019 10-K 2020-09-23
2018 $926K +$232K +33.4% Jul 1, 2017 Jun 30, 2018 10-K 2019-08-29
2017 $694K +$10K +1.46% Apr 1, 2017 Mar 31, 2018 10-Q 2018-05-09
2016 $684K -$295K -30.1% Apr 1, 2016 Mar 31, 2017 10-Q 2018-05-09
2015 $979K +$15K +1.56% Jul 1, 2014 Jun 30, 2015 10-K 2016-09-02
2014 $964K -$15K -1.53% Jul 1, 2013 Jun 30, 2014 10-K 2015-09-04
2013 $979K -$130K -11.7% Jul 1, 2012 Jun 30, 2013 10-K 2014-09-08
2012 $1.11M -$829K -42.8% Jul 1, 2011 Jun 30, 2012 10-K 2013-09-30
2011 $1.94M Jul 1, 2010 Jun 30, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.